Doctor's hand typing on laptop with stethoscope beside circular image


Life sciences and health care M&A update: Q1 2020

While adoption of virtual health will likely continue to accelerate in the short-term due to COVID-19, investment in the space may continue to grow in the long term if it is able to illustrate its potential. This life sciences and health care mergers and acquisitions (M&A) update provides Deloitte Corporate Finance LLC market data analysis that shed light on M&A trends in the life sciences and health care industry.

The role of virtual care in COVID-19 response

The role of virtual health: Six ways to increase capacity and protect existing supply1

Load-balance capacity: Virtual health makes it possible to tap into excess provider capacity in geographies that are not currently COVID-19 hotspots.

Reduce workforce exposure: Virtual health visits can help reduce staff exposure and lessen the use of personal protective equipment.

Overcome quarantine hurdles: Providers who need to self-quarantine can still tend to patients through virtual measures.

Scale scarce expertise: The limited capacity of intensive care physicians can be augmented by deploying e-ICU solutions.

Redeploy clinical experts: As elective procedures are delayed, those specialists could help with outpatient care/virtual health.

Expand capacity: Virtual health services can enable hospital-at-home solutions, allowing for more rapid discharge of patients and freeing up hospital capacity.

This newsletter is a periodic compilation of certain capital markets information. Information contained in this newsletter should not be construed as a recommendation to sell or a recommendation to buy any security. Any reference to or omission of any reference to any company in this newsletter shall not be construed as a recommendation to sell, buy, or take any other action with respect to any security of any such company. We are not soliciting any action with respect to any security or company based on this newsletter. This newsletter is published solely for the general information of clients and friends of Deloitte Corporate Finance LLC. It does not take into account the particular investment objectives, financial situation, or needs of individual recipients. Certain transactions, including those involving early-stage companies, give rise to substantial risk and are not suitable for all investors. This newsletter is based on information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. Prediction of future events is inherently subject to both known risks, uncertainties, and other factors that may cause actual results to vary materially. We are under no obligation to update the information contained in this newsletter. We and our affiliates and related entities, partners, principals, directors, and employees, including persons involved in the preparation or issuance of this newsletter, may from time to time have “long” and “short” positions in, and buy or sell, the securities, or derivatives (including options) thereof, of companies mentioned herein. The companies mentioned in this newsletter may be: (i) investment banking clients of Deloitte Corporate Finance LLC; or (ii) clients of Deloitte Financial Advisory Services LLP and its related entities. The decision to include any company for mention or discussion in this newsletter is wholly unrelated to any audit or other services that Deloitte Corporate Finance LLC may provide or to any audit services or any services that any of its affiliates or related entities may provide to such company. No part of this newsletter may be copied or duplicated in any form by any means, or redistributed without the prior written consent of Deloitte Corporate Finance LLC.


1Matthews, Felix and Urvi Shah. “How can virtual health help expand capacity in the wake of an anticipated COVID-19 surge?” Deloitte Health Forward Blog, March 26, 2020.

Did you find this useful?